Innovative development of biomedical technologies and medical devices for scientific research and IVD market
GBM scf-DNA
Vacuum tube for extraction, stabilization and storage of extracellular DNA. Read more...
GBM scf-RNA
A project to create a vacuum system for taking venous blood from a special stabilizer for free circulating RNA. The unique composition of the components allows them to stop the decay of free RNA in the patient's blood, and also blocks the release of new RNA into the plasma. Thus, this system will make it possible to obtain RNA for scientific and high-tech medical research of a patient. Estimated stabilization time for free circulating RNA after taking a blood sample: at least 7 days.
GBM Staburine
A project to create a stabilizer for urine bacteriology to enable delayed testing of urine sediment microscopy. The special composition of the components allows you to completely stop bacterial growth, while maintaining the viability of all types of detected bacteria. This stabilizer, in combination with a vacuum urine collection system, optimizes and significantly improves the accuracy of urine bacteriological analysis. Expected period of urine stabilization: at least 3 days.
GBM technology of PET hydrophobization
A project to create a technology for changing the structure of plastic (PET) vacuum tubes for taking biomaterials. The goal of the project is to significantly improve the properties of plastic in order to prevent water "evaporating" from the additives inside inside the finished vacuum systems. Expected result, economically viable technology that allows to modify PET vacuum systems and ensure the preservation of aqueous solutions for more than one year.
We are glad to cooperate in the framework of these projects, and we are also ready to participate in joint development of new products together with you!
Phone
+7 903 145-69-33
Viber/whatsapp
+7 903 145-69-33
gradbiomed2019@gmail.com
Unique team of specialists
Product quality
High reliability and stability
Convenience of working with us
High competitiveness
Efficiency
Dmitrii Gra: CEO
Victor Seleznev: CFO
Olga Gra, PhD: R&D Director